XML 91 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Taxation (Tables)
12 Months Ended
Dec. 31, 2022
Taxation  
Schedule of maximum applicable income tax rates of other countries

For the Year Ended December 31,

    

2020

    

2021

    

2022

    

United States

 

29.84

%  

29.84

%  

29.84

%  

United Kingdom

 

19.00

%  

19.00

%  

19.00

%  

Germany

 

32.98

%  

32.98

%  

32.98

%  

Norway

22.00

%  

22.00

%  

Netherlands

25.00

%  

25.80

%  

Schedule of composition of income tax expense

For the Year Ended December 31,

    

2020

    

2021

    

2022

Current income tax expense

6,368

23,565

62,348

Deferred income tax expense

18,700

(7,245)

Total

 

6,368

42,265

55,103

Schedule of reconciliation of the income tax expense

For the Year Ended December 31, 

    

2020

    

2021

    

2022

Loss before income tax expense

 

(5,297,714)

(3,974,684)

(14,382,001)

Income tax benefit computed at PRC statutory income tax rate of 25%

 

(1,324,429)

(993,671)

(3,595,500)

Non-deductible expenses

 

47,151

29,325

23,484

Foreign tax rates differential

 

(81,668)

100,690

395,543

Additional 100%/75% tax deduction for qualified research and development expenses

 

(36,775)

(546,805)

(750,736)

FDII Deduction

 

(10,356)

Tax exempted interest income

 

(2,194)

(8,847)

Non-taxable offshore income

 

(523,276)

US tax credits

(21,633)

(30,273)

(45,446)

Prior year True-ups

 

286,693

110,581

Effect of tax rate change

490,855

Prior year adjustments

(4,324)

Others

1,241

(1,206)

(5,154)

Change in valuation allowance

1,950,081

1,199,706

3,450,679

Income tax expense

 

6,368

42,265

55,103

Schedule of deferred tax assets and liabilities

As of December 31, 

    

2020

    

2021

    

2022

Deferred tax assets

 

  

 

  

 

  

Net operating loss carry-forwards

 

6,831,387

7,294,844

9,711,744

Accrued and prepaid expenses

 

534,693

1,136,278

1,666,519

Deferred revenue

251,778

559,815

940,633

Tax credit carry-forwards

 

233,326

243,198

301,437

Property, plant and equipment, net

 

64,191

Unrealized financing income

 

40,800

28,796

33,140

Intangible assets

36,702

85,439

89,328

Allowance against receivables

9,027

19,500

27,386

Deferred rent

 

9,791

29,731

Share-based compensation

 

6,857

10,695

6,951

Write-downs of inventory

1,162

713

452

Advertising expenses in excess of deduction limit

 

507

705

188

Equity securities with readily determinable fair value

150

Unrealized foreign exchange loss

 

(971)

1,704

Others

269

711

4,224

Less: Valuation allowance

 

(8,019,519)

(9,216,725)

(12,727,355)

Subtotal

163,969

86,232

Deferred tax liabilities

Equity securities without readily determinable fair value

(15,975)

(6,435)

Equity securities with readily determinable fair value

(2,725)

Equity method investments

(5,170)

Available for sale debt investment

(6,499)

(206,734)

Property, plant and equipment, net

(143,512)

(86,082)

Deferred rent

(18,752)

Unrealized foreign exchange loss

(1,705)

Subtotal

(189,168)

(304,421)

Total deferred tax liabilities, net

 

(25,199)

(218,189)

Schedule of valuation allowance

As of December 31, 

    

2020

    

2021

    

2022

Valuation allowance

 

  

 

  

 

  

Balance at beginning of the year

 

6,879,030

8,019,519

9,216,725

Additions

 

1,140,489

1,199,706

3,510,630

Balance at end of the year

 

8,019,519

9,216,725

12,727,355

Schedule of tax losses expiration dates

Loss expiring in 2023

    

1,213,835

Loss expiring in 2024

 

2,356,711

Loss expiring in 2025

 

4,094,099

Loss expiring in 2026

 

7,191,472

Loss expiring in 2027

    

9,090,262

Loss expiring in 2028

1,606,792

Loss expiring in 2029

5,334,423

Loss expiring in 2030

Loss expiring in 2031

Loss expiring in 2032

7,091,436

Total

 

37,979,030